Novartis updates Phase IIIb ribociclib adjuvant breast cancer trial; four prior items holdOct 23Weekly roundup, 5 itemsarumakimigNovartisUpdated
Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeOct 2Weekly roundup, 10 itemsarumakimigatrasentanUpdated
Novartis registers Phase 2 VEXAS trial for arumakimig; posts MS treatment-pattern study resultsAug 6Weekly roundup, 2 itemsarumakimigNovartis